Willow Biosciences (TSE:WLLW) Shares Up 25% – Should You Buy?

Willow Biosciences Inc. (TSE:WLLWGet Free Report)’s share price shot up 25% on Thursday . The stock traded as high as C$0.03 and last traded at C$0.03. 193,916 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 616,566 shares. The stock had previously closed at C$0.02.

Willow Biosciences Stock Performance

The company has a debt-to-equity ratio of 131.61, a current ratio of 0.70 and a quick ratio of 19.71. The company has a market cap of C$3.61 million, a price-to-earnings ratio of -0.42 and a beta of 1.13. The firm has a 50 day simple moving average of C$0.06 and a 200-day simple moving average of C$0.08.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

See Also

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.